<DOC>
	<DOC>NCT00637559</DOC>
	<brief_summary>This study looks the intragastric and intraesophageal pH in patients with documented Barrett's esophagus whilst taking esomeprazole 40mg twice daily, esomeprazole 40mg three times daily, esomeprazole 20 mg three times daily.</brief_summary>
	<brief_title>Barrett's Esophagus - 315 - 3 Way Cross-Over</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Must have a previously established, biopsyproven diagnosis of Barrett's esophagus with segment length greater than 3cm, with no dysplasia or adenocarcinoma within the previous 12 months A history of esophageal, gastric, or duodenal surgery, including antireflux surgery or endoscopic antireflux procedures, except for simple closure of a gastric or duodenal ulcer. History of various gastrointestinal diseases please see investigator for full list. Evidence of any malignant disease in the last 5 years, except minor superficial skin disease. Unstable diabetes mellitus. Stable on a controlled diet, oral agents or insulin are acceptable.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Nexium</keyword>
	<keyword>Barrett's esophagus</keyword>
</DOC>